How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension　― A Report From a Referral Center in Japan ―

Tamura, Yuichi; Takeyasu, Rika; Furukawa, Asuka; Takada, Hiromi; Takechi, Mineki; Taniguchi, Hirohisa; Kawamura, Akio

doi:10.1253/circrep.cr-20-0088

Cited by 6 publications

(3 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Global studies of oncology and COVID-19 also suggest the use of telehealth, avoidance of non-essential visits, and minimization of exposure periods [43][44][45]48]. Although there is some evidence of changes in medical encounters in other chronic disease practices in Japan [49][50][51] and increased use of telemedicine in some centers [52], the widespread use of telemedicine and treatment changes in oncology remains limited and cannot be well observed in this claims database study.…”

Section: Discussionmentioning

confidence: 94%

Economic Burden in Treated Japanese Patients with Relapsed/Refractory Large B-Cell Lymphoma

Tsutsué

Makita

Yi³

et al. 2021

Future Oncol.

View full text Add to dashboard Cite

Aim: To understand the economic burden of relapsed and refractory large B-cell lymphoma patients in Japan treated with salvage chemotherapy. Patients & methods: Patients who received systemic therapy after first-line treatment were analyzed to assess its associated cost and resource use using a retrospective claims database. The impact of COVID-19 was assessed separately. Results & conclusion: This study identified 2927 and 1085 patients in the second- (2L) and third-line (3L) cohorts. The median ages for the 2L and 3L cohorts were 71 and 70 years, respectively, with Charlson Comorbidity Score of 3. A majority of the patients had limited stem cell transplant due to advanced age. Median lengths of inpatient stay for the 2L and 3L cohorts were 118 and 116 days, respectively. The majority of costs were attributed to inpatient costs, and limited COVID-19 impact was observed in this study.

show abstract

Section: Discussionmentioning

confidence: 94%

Economic Burden in Treated Japanese Patients with Relapsed/Refractory Large B-Cell Lymphoma

Tsutsué

Makita

Yi³

et al. 2021

Future Oncol.

View full text Add to dashboard Cite

show abstract

“…The increased remote working environments as well as the availability of alternative services such as telemedicine, home/food deliveries, may have potentially reduced the ambient exposure of the population [ 41 ]. Early in the pandemic, on March 2020, the Japanese government encouraged firms to integrate a work-from-home setting to avoid cluster infections within workplaces.…”

Section: Discussionmentioning

confidence: 99%

COVID-19 pandemic modifies temperature and heat-related illness ambulance transport association in Japan: a nationwide observational study

Seposo

Madaniyazi

et al. 2021

Environ Health

View full text Add to dashboard Cite

Background During the COVID-19 pandemic, several illnesses were reduced. In Japan, heat-related illnesses were reduced by 22% compared to pre-pandemic period. However, it is uncertain as to what has led to this reduction. Here, we model the association of maximum temperature and heat-related illnesses in the 47 Japanese prefectures. We specifically examined how the exposure and lag associations varied before and during the pandemic. Methods We obtained the summer-specific, daily heat-related illness ambulance transport (HIAT), exposure variable (maximum temperature) and covariate data from relevant data sources. We utilized a stratified (pre-pandemic and pandemic), two-stage approach. In each stratified group, we estimated the 1) prefecture-level association using a quasi-Poisson regression coupled with a distributed lag non-linear model, which was 2) pooled using a random-effects meta-analysis. The difference between pooled pre-pandemic and pandemic associations was examined across the exposure and the lag dimensions. Results A total of 321,655 HIAT cases was recorded in Japan from 2016 to 2020. We found an overall reduction of heat-related risks for HIAT during the pandemic, with a wide range of reduction (10.85 to 57.47%) in the HIAT risk, across exposure levels ranging from 21.69 °C to 36.31 °C. On the contrary, we found an increment in the delayed heat-related risks during the pandemic at Lag 2 (16.33%; 95% CI: 1.00, 33.98%). Conclusion This study provides evidence of the impact of COVID-19, particularly on the possible roles of physical interventions and behavioral changes, in modifying the temperature-health association. These findings would have implications on subsequent policies or heat-related warning strategies in light of ongoing or future pandemics.

show abstract

“…After COVID-19 pandemic onset and diffusion, the rapid involvement of millions of people worldwide forced local and national healthcare systems to adopt telemedicine for ensuring baseline and, in some selected cases, advanced healthcare supports. This was the case for several chronic progressive cardiovascular diseases, such as pulmonary hypertension [46], congestive heart failure [47][48][49] and chronic kidney disease [50], but also for non-cardiovascular diseases, mostly onco-hematologic diseases [51,52]. Among these conditions, essential hypertension represents an ideal target for telemedicine, since: (1) it affects In addition, participants with inadequate BP control at recruitment might gain more benefits with mHealth intervention [63] millions of people across all age, gender, and ethnic groups almost in all countries all over the world; (2) it requires periodic assessment of both vital signs (i.e., BP levels) and adherence to prescribed interventions (life-style changes and/or drug therapies); it is highly affected and positively influenced by frequent interactions between patients and health care providers from both educational and therapeutic point of views.…”

Section: Telemedicine Home Blood Pressure and Covid-19mentioning

confidence: 91%

Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic

Citoni¹,

Figliuzzi²,

Presta³

et al. 2021

High Blood Press Cardiovasc Prev

View full text Add to dashboard Cite

Hypertension is the most common cardiovascular risk factor for acute cardiovascular outcomes, including acute coronary disease, stroke, chronic kidney disease and congestive heart failure. Despite the fact that it represents the most prevalent risk factor in the general population, mostly in elderly individuals, its awareness is still relatively low, being about one third of patients living with undiagnosed hypertension and high risk of experiencing acute cardiovascular events. In addition, though recent improvement in pharmacological and non-pharmacological therapeutic options, hypertension is largely uncontrolled, with about 35-40% of treated hypertensive patients achieving the recommended therapeutic targets. Among different modern interventions proposed for improving blood pressure control in treated hypertensive patients, a systematic adoption of home BP monitoring has demonstrated to be one of the most effective. Indeed, it improves patients' awareness of the disease and adherence to prescribed medications and allows tailoring and personalizing BP lowering therapies. Home BP monitoring is particularly suitable for telemedicine and mobile-health solutions. Indeed, in specific conditions, when face-to-face interactions between patients and physicians are not allowed or even suspended, as in case of COVID-19 pandemic, telemedicine may ensure effective management of hypertension, as well as other cardiovascular and non-cardiovascular comorbidities. This review will summarize strengths and limitations of telemedicine in the clinical management of hypertension with a particular focus on the lessons learned during the COVID-19 pandemic. KeywordsHypertension • Blood pressure • Telemedicine • Telemonitoring • Home blood pressure monitoring • COVID-19 This article is part of the topical collection on Epidemiology of Hypertension.

show abstract

How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension　― A Report From a Referral Center in Japan ―

Cited by 6 publications

References 14 publications

Economic Burden in Treated Japanese Patients with Relapsed/Refractory Large B-Cell Lymphoma

Economic Burden in Treated Japanese Patients with Relapsed/Refractory Large B-Cell Lymphoma

COVID-19 pandemic modifies temperature and heat-related illness ambulance transport association in Japan: a nationwide observational study

Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic

Contact Info

Product

Resources

About

How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension ― A Report From a Referral Center in Japan ―

Cited by 6 publications

References 14 publications

Economic Burden in Treated Japanese Patients with Relapsed/Refractory Large B-Cell Lymphoma

Economic Burden in Treated Japanese Patients with Relapsed/Refractory Large B-Cell Lymphoma

COVID-19 pandemic modifies temperature and heat-related illness ambulance transport association in Japan: a nationwide observational study

Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic

Contact Info

Product

Resources

About

How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension　― A Report From a Referral Center in Japan ―